axelroark

IBB Breakdown After Back Test

做空
NASDAQ:IBB   iShares Biotechnology ETF
IBB is showing weakness, having broken through a key support area and then failed to recover in day 1 of the back test. Expect to see re-test of 98'ish support, with failure leading to a re-test of December 2018 lows, and perhaps much lower. Bang for buck isn't great here, so we aren't taking the trade, but risk/reward is very good on this move.

免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。